Pneumocystis Pneumonia Developing during Treatment of Recurrent Renal Cell Cancer with Nivolumab / 대한내과학회지
Korean Journal of Medicine
;
: 571-574, 2018.
Article
in Korean
| WPRIM
| ID: wpr-718858
ABSTRACT
Nivolumab is an immune checkpoint inhibitor approved for the treatment of metastatic cancers. Here, we report the case of a 65-year-old male with recurrent renal cell carcinoma. After six cycles of nivolumab treatment, positron emission tomography/computed tomography (PET/CT) was performed to evaluate the response. PET/CT revealed diffuse ground glass opacities in both lungs. He developed a cough, sputum, chills, and a febrile sense. After bronchoscopic bronchoalveolar lavage, pneumocystis pneumonia was finally diagnosed.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Pneumocystis
/
Pneumonia
/
Pneumonia, Pneumocystis
/
Sputum
/
Carcinoma, Renal Cell
/
Bronchoalveolar Lavage
/
Cough
/
Chills
/
Electrons
/
Positron Emission Tomography Computed Tomography
Limits:
Aged
/
Humans
/
Male
Language:
Korean
Journal:
Korean Journal of Medicine
Year:
2018
Type:
Article
Similar
MEDLINE
...
LILACS
LIS